Will Haemonetics (HAE) Beat Estimates Again in Its Next Earnings Report?

Core Insights - Haemonetics is well-positioned to continue its earnings-beat streak, having a history of exceeding earnings estimates, particularly in the last two quarters with an average surprise of 11.15% [1] Earnings Performance - In the last reported quarter, Haemonetics achieved earnings of $1.27 per share, surpassing the Zacks Consensus Estimate of $1.12 per share, resulting in a surprise of 13.39% [2] - In the previous quarter, the company was expected to report earnings of $1.01 per share but delivered $1.10 per share, yielding a surprise of 8.91% [2] Earnings Estimates - There has been a favorable change in earnings estimates for Haemonetics, with a positive Earnings ESP (Expected Surprise Prediction) indicating a strong likelihood of an earnings beat [5] - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests that stocks with this profile beat consensus estimates nearly 70% of the time [6] Earnings ESP Analysis - Haemonetics currently has an Earnings ESP of +0.79%, indicating that analysts have recently become more optimistic about the company's earnings prospects [8] - The next earnings report for Haemonetics is expected to be released on February 5, 2026 [8]